SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000920465-20-000055
Filing Date
2020-04-29
Accepted
2020-04-29 17:06:59
Documents
4
Period of Report
2020-06-25
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxy2020.htm DEF 14A 761721
2 image1a08.jpg GRAPHIC 164429
3 lajolla2019proxycard01page1.jpg GRAPHIC 215029
4 lajolla2019proxycard01page2.jpg GRAPHIC 263802
  Complete submission text file 0000920465-20-000055.txt   1649043
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36282 | Film No.: 20831447
SIC: 2836 Biological Products, (No Diagnostic Substances)